AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23048056 — intervention group
Group type: COMPARATOR
Intervention: High-dose clopidogrel (150 mg/day)
Number of subjects: 32
Study 23048056 — intervention group
Group type: COMPARATOR
Intervention: CYP2C19*2 noncarriers (high-dose clopidogrel)
Number of subjects: 32
Study 23048056 — intervention group
Group type: COMPARATOR
Intervention: CYP2C19*2 carriers (high-dose clopidogrel)
Number of subjects: 32
Study 19745764 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg oral once daily
Number of subjects: 64
Study 17513627 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP of 6-cm H2O
Number of subjects: 46
Study 17513627 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 3-cm H2O
Number of subjects: 46
Study 15386325 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 0
Study 15386325 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopic surgery
Number of subjects: 0
Study 11263473 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I (20 microg/kg s.c. at -180 min)
Number of subjects: 6
Study 11263473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 11263473 — intervention group
Group type: EXPERIMENTAL
Intervention: hCRH (2.0 microg/kg i.v. at 0 min)
Number of subjects: 6
Study 11263473 — intervention group
Group type: EXPERIMENTAL
Intervention: HEX (2.0 microg/kg i.v. at 0 min)
Number of subjects: 6
Study 11263473 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I
Number of subjects: 6
Study 11263473 — intervention group
Group type: EXPERIMENTAL
Intervention: HEX
Number of subjects: 6
Study 10459091 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed normal saline solution
Number of subjects: 40
Study 10459091 — intervention group
Group type: COMPARATOR
Intervention: Room temperature saline solution
Number of subjects: 40
Study 8682087 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment in autoreactive forms of myocarditis
Number of subjects: 0
Study 8682087 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperimmunoglobulin therapy
Number of subjects: 0
Study 8682087 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulating factors (e.g., ribaverin, interleukins, interferons)
Number of subjects: 0
Study 1967500 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 0.75 mg
Number of subjects: 36
Study 1967500 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 1.5 mg
Number of subjects: 36
Study 1967500 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 36
Study 1967500 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 36
Study 1967500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 345534 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenine arabinoside ointment
Number of subjects: 60
Study 345534 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxuridine ointment
Number of subjects: 60
Study 345534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31103365 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN-003 (60 µg antigen/50 µg M2)
Number of subjects: 3
Study 31103365 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN-003 (60 µg/75 µg M2)
Number of subjects: 3
Study 31103365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 28969328 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoelastometry guided fresh frozen plasma (FFP) infusion
Number of subjects: 605
Study 25533539 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB) titrated to effect, starting at 4.5 g/night and adjusted based on clinical response, for a duration of 12 weeks.
Number of subjects: 202
Study 23461778 — intervention group
Group type: EXPERIMENTAL
Intervention: Altemeier's procedure
Number of subjects: 293
Study 23461778 — intervention group
Group type: COMPARATOR
Intervention: Delorme's procedure
Number of subjects: 293
Study 23461778 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection rectopexy
Number of subjects: 293
Study 23461778 — intervention group
Group type: COMPARATOR
Intervention: Suture rectopexy
Number of subjects: 293
Study 23461778 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal surgery
Number of subjects: 293
Study 23461778 — intervention group
Group type: COMPARATOR
Intervention: Abdominal surgery
Number of subjects: 293
Study 21338492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided fascia iliaca block using levobupivacaine, plus spinal anaesthesia with hyperbaric bupivacaine containing no morphine
Number of subjects: 108
Study 21338492 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound guided fascia iliaca block performed with sterile saline, and spinal anaesthesia containing hyperbaric bupivacaine and 0.1 mg of spinal morphine
Number of subjects: 108
Study 19470062 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% and salicylic acid 5% for the first 7 days, followed by mometasone furoate 0.1% for 14 days
Number of subjects: 360
Study 19470062 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate 0.1% for 21 consecutive days
Number of subjects: 360
Study 19470062 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% and salicylic acid 5% followed by mometasone furoate 0.1%
Number of subjects: 360
Study 16988939 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal counseling (IPC), 1 to 6 weekly sessions, telephone-administered
Number of subjects: 17
Study 15188834 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal FSH levels
Number of subjects: 144
Study 15188834 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate challenge test (CCCT)
Number of subjects: 144
Study 15188834 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist stimulation test (GAST)
Number of subjects: 144
Study 15188834 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound for ovarian volume measurements
Number of subjects: 144
Study 11879297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening programs for elderly women
Number of subjects: 0
Study 10195048 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer led intervention delivered by trained volunteers aged 16-17 years
Number of subjects: 500
Study 10195048 — intervention group
Group type: COMPARATOR
Intervention: Usual teacher led sex education
Number of subjects: 500
Study 1637758 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweeping of the membranes
Number of subjects: 65
Study 1637758 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 65
Study 6478137 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct cervical puncture technique
Number of subjects: 300
Study 6478137 — intervention group
Group type: COMPARATOR
Intervention: Lumbar puncture with run-up technique
Number of subjects: 300
Study 31515397 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic therapies
Number of subjects: 0
Study 31515397 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29753356 — intervention group
Group type: EXPERIMENTAL
Intervention: Bring Your Own Device (BYOD)
Number of subjects: 155
Study 29753356 — intervention group
Group type: COMPARATOR
Intervention: Site device
Number of subjects: 155
Study 29753356 — intervention group
Group type: COMPARATOR
Intervention: Paper
Number of subjects: 155
Study 29753356 — intervention group
Group type: EXPERIMENTAL
Intervention: BYOD
Number of subjects: 155
Study 27120317 — intervention group
Group type: EXPERIMENTAL
Intervention: Standalone computer-delivered brief intervention (BI)
Number of subjects: 836
Study 27120317 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-delivered brief intervention (BI)
Number of subjects: 836
Study 27120317 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 836
Study 24084071 — intervention group
Group type: EXPERIMENTAL
Intervention: LABA step-up therapy
Number of subjects: 0
Study 24084071 — intervention group
Group type: EXPERIMENTAL
Intervention: LTRA step-up therapy
Number of subjects: 0
Study 24084071 — intervention group
Group type: COMPARATOR
Intervention: ICS step-up therapy
Number of subjects: 0
Study 21113076 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐Chasqui web‐based information system (intervention group)
Number of subjects: 78
Study 21113076 — intervention group
Group type: COMPARATOR
Intervention: Paper-based system (control group)
Number of subjects: 78
Study 19404073 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoma patients (temporary or permanent)
Number of subjects: 186
Study 19404073 — intervention group
Group type: COMPARATOR
Intervention: Non-stoma patients
Number of subjects: 186
Study 17515847 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented formula (FF) with Bifidobacterium breve C50 and Streptococcus thermophilus 065
Number of subjects: 90
Study 17515847 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 90
Study 17515847 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed group
Number of subjects: 90
Study 15106502 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0
Study 11696139 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard insertion technique
Number of subjects: 80
Study 11696139 — intervention group
Group type: COMPARATOR
Intervention: Partially inflated cuff insertion technique
Number of subjects: 80
Study 9738173 — intervention group
Group type: EXPERIMENTAL
Intervention: Palivizumab (15 mg/kg)
Number of subjects: 1502
Study 8731298 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) 160 UaXa IC/kg/day (group IA)
Number of subjects: 314
Study 8731298 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) 320 UaXa IC/kg/day (group IB)
Number of subjects: 314
Study 8731298 — intervention group
Group type: COMPARATOR
Intervention: Intravenous non-fractioned heparin (NFH) 100UI/kg (bolus), followed by 1000UI/h
Number of subjects: 314
Study 2663639 — intervention group
Group type: EXPERIMENTAL
Intervention: Othmer and DeSouza's screening index
Number of subjects: 100
Study 2663639 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS-derived screening index
Number of subjects: 100
Study 893685 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic subtypes (process, reactive, paranoid, nonparanoid, long‐ and short‐hospitalization, long‐ and short‐length of illness)
Number of subjects: 0
Study 893685 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched groups of schizophrenic subtypes
Number of subjects: 0
Study 31125163 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention: Protocol for early mobilization in ICUs.
Number of subjects: 272
Study 31125163 — intervention group
Group type: COMPARATOR
Intervention: Control: Standard care without the protocol for early mobilization.
Number of subjects: 272
Study 30771641 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 78
Study 30771641 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 78
Study 26911485 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 60)
Number of subjects: 127
Study 26911485 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 67)
Number of subjects: 127
Study 26269615 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.5 mg/kg/dose
Number of subjects: 0
Study 26269615 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg/kg/dose
Number of subjects: 0
Study 26269615 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 5.0 mg/kg/dose
Number of subjects: 0
Study 26269615 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study 23615578 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal working memory training
Number of subjects: 36
Study 23615578 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 36
Study 21995648 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin methanesulfonate sodium (CMS‐Na) 2.5 mg/kg as colistin activity, 75,000 IU/kg, twice daily repeat doses
Number of subjects: 22
Study 21995648 — intervention group
Group type: COMPARATOR
Intervention: Colistin methanesulfonate sodium (CMS‐Na) 2.5 mg/kg as colistin activity, 75,000 IU/kg, single dose
Number of subjects: 22
Study 21995648 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin methanesulfonate sodium (CMS‐Na)
Number of subjects: 22
Study 19154837 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal oxygen uptake (VO2max) estimated from a modified submaximal Astrand bicycle test
Number of subjects: 223
Study 19154837 — intervention group
Group type: EXPERIMENTAL
Intervention: Levels of activity during leisure time and work/household
Number of subjects: 223
Study 19154837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear avoidance model variables
Number of subjects: 223
Study 17034280 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation via an ECG electrode
Number of subjects: 15
Study 17034280 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual stimulation via an acupuncture needle
Number of subjects: 15
Study 17034280 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation via an acupuncture needle
Number of subjects: 15
Study 17034280 — intervention group
Group type: COMPARATOR
Intervention: Control location (NP)
Number of subjects: 15
Study 12737246 — intervention group
Group type: EXPERIMENTAL
Intervention: In-Ceram Alumina FPDs
Number of subjects: 37
Study 10679652 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg/day megestrol acetate (low dose)
Number of subjects: 149
Study 10679652 — intervention group
Group type: EXPERIMENTAL
Intervention: 640 mg/day megestrol acetate (high dose)
Number of subjects: 149
Study 10072958 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic bendazac lysine tablet
Number of subjects: 10
Study 10072958 — intervention group
Group type: COMPARATOR
Intervention: Imported bendazac lysine tablet
Number of subjects: 10
Study 8174201 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
Number of subjects: 52
Study 8174201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 3344298 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 0 mg (placebo)
Number of subjects: 36
Study 3344298 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 125 mg
Number of subjects: 36
Study 3344298 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg
Number of subjects: 36
Study 3344298 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 36
Study 3344298 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (any dose)
Number of subjects: 36
Study 30824960 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary skin closure with a contralateral Penrose® drain
Number of subjects: 70
Study 30824960 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary skin closure
Number of subjects: 70
Study 28289240 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (6 g daily for 3 days)
Number of subjects: 256
Study 28289240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 26621127 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable colon
Number of subjects: 273
Study 26621127 — intervention group
Group type: COMPARATOR
Intervention: Standard display table method
Number of subjects: 273
Study 23195389 — intervention group
Group type: EXPERIMENTAL
Intervention: Core‐Palliative Care Outcome Scale (Core‐POS)
Number of subjects: 46
Study 23195389 — intervention group
Group type: EXPERIMENTAL
Intervention: POS‐MS‐Symptoms (POS‐MS‐S)
Number of subjects: 46
Study 23195389 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct validity of Core‐POS and POS‐MS‐S
Number of subjects: 46
Study 21328205 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-sensory environment therapy (24 sessions over 12 weeks)
Number of subjects: 20
Study 21328205 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing home care (control group)
Number of subjects: 20
Study 19690245 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative NG tube use
Number of subjects: 4055
Study 19690245 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative NG tube use
Number of subjects: 4055
Study 16371613 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microg x kg(‐1) fentanyl and 0.02 mg x kg(‐1) midazolam intravenously
Number of subjects: 60
Study 16371613 — intervention group
Group type: COMPARATOR
Intervention: iv saline (control)
Number of subjects: 60
Study 12723100 — intervention group
Group type: EXPERIMENTAL
Intervention: New CrossAction manual toothbrush
Number of subjects: 15
Study 12723100 — intervention group
Group type: COMPARATOR
Intervention: Worn CrossAction manual toothbrush
Number of subjects: 15
Study 12723100 — intervention group
Group type: EXPERIMENTAL
Intervention: New Braun Oral‐B Battery (D4) toothbrush
Number of subjects: 15
Study 12723100 — intervention group
Group type: COMPARATOR
Intervention: Worn Braun Oral‐B Battery (D4) toothbrush
Number of subjects: 15
Study 10785215 — intervention group
Group type: EXPERIMENTAL
Intervention: Short protocol (group 3)
Number of subjects: 150
Study 10785215 — intervention group
Group type: EXPERIMENTAL
Intervention: Long protocol starting on day 2 (group 1)
Number of subjects: 150
Study 10785215 — intervention group
Group type: EXPERIMENTAL
Intervention: Long protocol starting on day 21 (group 2)
Number of subjects: 150
Study 9484163 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBond adhesive liner
Number of subjects: 60
Study 9484163 — intervention group
Group type: COMPARATOR
Intervention: Conventional liners and bases
Number of subjects: 60
Study 8396608 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% all-trans retinoic acid cream
Number of subjects: 25
Study 8396608 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% CD271 gel
Number of subjects: 25
Study 8396608 — intervention group
Group type: COMPARATOR
Intervention: all-trans retinoic acid vehicle
Number of subjects: 25
Study 8396608 — intervention group
Group type: COMPARATOR
Intervention: CD271 vehicle
Number of subjects: 25
Study 3085363 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg b.d. ranitidine
Number of subjects: 48
Study 3085363 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg b.d. ranitidine
Number of subjects: 48
Study 3085363 — intervention group
Group type: COMPARATOR
Intervention: 75 mg nocte ranitidine for prophylaxis
Number of subjects: 48
Study 3085363 — intervention group
Group type: COMPARATOR
Intervention: 150 mg nocte ranitidine for prophylaxis
Number of subjects: 48
Study 30683825 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg three times daily)
Number of subjects: 114
Study 30683825 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg twice daily)
Number of subjects: 114
Study 30683825 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calorie diet (LC)
Number of subjects: 114
Study 30683825 — intervention group
Group type: COMPARATOR
Intervention: Control group (isocaloric diet)
Number of subjects: 114
Study 27042999 — intervention group
Group type: EXPERIMENTAL
Intervention: VARIED (2-4 RM on Day 1, 8-12 RM on Day 2, 20-30 RM on Day 3 for 8 weeks)
Number of subjects: 19
Study 27042999 — intervention group
Group type: COMPARATOR
Intervention: CONSTANT (8-12 RM per set for 8 weeks)
Number of subjects: 19
Study 24991872 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEEs, 0.625 mg/day)
Number of subjects: 27347
Study 24991872 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens and medroxyprogesterone acetate (MPA, 2.5 mg/day)
Number of subjects: 27347
Study 24991872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27347
Study 23469188 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically integrated post‐graduate training programme in evidence-based medicine (5-day training including assignments, peer teaching, interactive training, lectures, brainstorming sessions)
Number of subjects: 132
Study 23469188 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 132
Study 20962743 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum bicarbonate levels (20-30 mmol/l)
Number of subjects: 1094
Study 20962743 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum bicarbonate levels near 28-30 mmol/l
Number of subjects: 1094
Study 18985810 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 674
Study 16611442 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation A (locally manufactured SP tablet formulation, 500 mg sulfadoxine and 25 mg pyrimethamine)
Number of subjects: 12
Study 16611442 — intervention group
Group type: COMPARATOR
Intervention: Formulation B (Fansidar, Hoffmann La Roche, Basel, Switzerland, 500 mg sulfadoxine and 25 mg pyrimethamine)
Number of subjects: 12
Study 14514234 — intervention group
Group type: EXPERIMENTAL
Intervention: PLGA (10 recessions)
Number of subjects: 22
Study 14514234 — intervention group
Group type: EXPERIMENTAL
Intervention: SDDA (10 recessions)
Number of subjects: 22
Study 14514234 — intervention group
Group type: EXPERIMENTAL
Intervention: CTG (10 recessions)
Number of subjects: 22
Study 10646612 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 17
Study 10646612 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 17
Study 10646612 — intervention group
Group type: EXPERIMENTAL
Intervention: SCID II
Number of subjects: 17
Study 8665770 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure at -15 mmHg
Number of subjects: 14
Study 8665770 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure at -40 mmHg
Number of subjects: 14
Study 1679076 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal cleansing
Number of subjects: 192
Study 1679076 — intervention group
Group type: COMPARATOR
Intervention: Non-cleansing
Number of subjects: 192
Study 6800389 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg orally)
Number of subjects: 7
Study 6800389 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (200 mg orally)
Number of subjects: 7